Nan Fung Life Sciences Real Estate (NFLSRE) today announced the acquisition of 51 Sleeper Street in Boston from Brookfield Properties. Located in the Seaport District, the 152,102 sq. ft, eight floor building is ideally located in one of Boston’s leading – and growing – neighborhoods.

Based in Boston MA, NFLSRE is led by a world class management team with over 75 years of combined life sciences real estate development and operations experience.

“The need for innovative and scalable research laboratory space in Boston is high, we are proud to be able to provide the resources for more companies to grow here,” said Matthew Powers, CEO of Nan Fung Life Sciences Real Estate. “We are thankful to Brookfield Properties, Ben Brown, and his team for working with us to make this happen. Together, we were able to reach an agreement that not only works for both parties involved – but benefits the City of Boston. We look forward to working with the City to continue growing this important industry.”

NFLSRE is a subsidiary of Nan Fung Group, a privately held Hong Kong based global conglomerate with core businesses in real estate development and investment. The Group’s real estate business is vertically integrated with investment, development and operating capabilities in Hong Kong, China, the United Kingdom and the United States. The Group also holds a well-diversified financial investment portfolio and has made significant investments in the life science sector globally through Nan Fung Life Sciences.

Nan Fung Life Sciences has $1.5 billion capital commitment from Nan Fung Group to invest into life sciences and has invested in 46 portfolio companies to date.

About Nan Fung Life Sciences Real Estate

Nan Fung Life Sciences Real Estate (“NFLSRE”), a subsidiary of Nan Fung Group, is an innovative, premier real estate investment and operating company based in Boston MA. NFLSRE is led by a world class management team with over 75 years of combined life sciences real estate development and operations experience. For more information please visit https://www.nanfunglsre.com/.

About Nan Fung Life Sciences

Nan Fung Life Sciences, part of Nan Fung Group, is a global investment platform focusing on life sciences. Leveraging on Nan Fung Group’s strong capital base and long-term commitment to the area, the company is aimed to become the ideal partner for scientists, entrepreneurs, corporations and investors in the life science space. Through direct investments via Pivotal BioVenture Partners funds (both in the US and China) and fund investments covering full spectrum of the industry (including therapeutics, medical devices and diagnostics) and across different development stages, Nan Fung Life Sciences has significant presence in both the US and Greater China.

About Nan Fung Group

Founded in 1954, Nan Fung Group is a Hong Kong-based property developer and investor with net assets around $13 billion. To date, Nan Fung Group’s track record spans over 165 projects comprising over 66 million square feet. Outside of Hong Kong, Nan Fung Group’s property portfolio also covers various first tier cities in China; as well as London and New York. Nan Fung Group also holds a well-diversified, substantial financial investment portfolio consisting of stocks, bonds, debt, funds, private equity and venture capital investments.